{"id":"https://openalex.org/W1491963713","doi":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","title":"Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment","display_name":"Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-30","ids":{"openalex":"https://openalex.org/W1491963713","doi":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","mag":"1491963713","pmid":"https://pubmed.ncbi.nlm.nih.gov/15992385"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.2005.03192.x","doi":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1491963713"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043164122","display_name":"Rosa Mar\u00eda Tordera","orcid":"https://orcid.org/0000-0002-3564-4135","observed_orcids":["https://orcid.org/0000-0002-3564-4135"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rosa M. Tordera","raw_affiliation_strings":["University Department of Pharmacology, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Pharmacology, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030939361","display_name":"Qi Pei","orcid":"https://orcid.org/0000-0002-6711-4251","observed_orcids":["https://orcid.org/0000-0002-6711-4251"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qi Pei","raw_affiliation_strings":["University Department of Pharmacology, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Pharmacology, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016717006","display_name":"Trevor Sharp","orcid":"https://orcid.org/0000-0001-7434-9713","observed_orcids":["https://orcid.org/0000-0001-7434-9713"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Trevor Sharp","raw_affiliation_strings":["University Department of Pharmacology, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Pharmacology, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5016717006"],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":2.8763,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.90380117,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"94","issue":"4","first_page":"875","last_page":"883"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6693999767303467,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.6693999767303467,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.31690001487731934,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vglut1","display_name":"VGLUT1","score":0.9160000085830688},{"id":"https://openalex.org/keywords/vesicular-glutamate-transporter","display_name":"vesicular glutamate transporter","score":0.9210000038146973},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.9660000205039978},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8759999871253967},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":1.0},{"id":"https://openalex.org/keywords/electroconvulsive-shock","display_name":"electroconvulsive shock","score":0.9879999756813049},{"id":"https://openalex.org/keywords/glutamate-release","display_name":"glutamate release","score":0.7059999704360962},{"id":"https://openalex.org/keywords/gene-expression","display_name":"gene expression","score":0.6909999847412109},{"id":"https://openalex.org/keywords/neuroplasticity","display_name":"neuroplasticity","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.7459999918937683},{"id":"https://openalex.org/keywords/vglut2","display_name":"VGLUT2","score":0.9459999799728394},{"id":"https://openalex.org/keywords/vesicular-glutamate-transporter-3","display_name":"VGLUT3","score":0.9769999980926514},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.925000011920929},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":1.0}],"concepts":[{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.8170503377914429},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5855682492256165},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.529496967792511},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.5215936899185181},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4960361421108246},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.44137316942214966},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3973534107208252},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3501683473587036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2876458764076233},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2753538489341736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.272544801235199},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.2707964777946472},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2422333061695099}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004597","descriptor_name":"Electroshock","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D026922","descriptor_name":"Amino Acid Transport Systems, Acidic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050496","descriptor_name":"Vesicular Glutamate Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050598","descriptor_name":"Vesicular Glutamate Transport Protein 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050599","descriptor_name":"Vesicular Glutamate Transport Protein 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1471-4159.2005.03192.x","doi":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2005.03192.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:15992385","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15992385","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W107719831","https://openalex.org/W1004807211","https://openalex.org/W1489716577","https://openalex.org/W1630907922","https://openalex.org/W1806484438","https://openalex.org/W1954025536","https://openalex.org/W1966023781","https://openalex.org/W1969216814","https://openalex.org/W1970658476","https://openalex.org/W1974742716","https://openalex.org/W1977237592","https://openalex.org/W1983885652","https://openalex.org/W1986881967","https://openalex.org/W1994702289","https://openalex.org/W1997137464","https://openalex.org/W2001834798","https://openalex.org/W2002282047","https://openalex.org/W2006869925","https://openalex.org/W2010633131","https://openalex.org/W2016565942","https://openalex.org/W2018576843","https://openalex.org/W2021248045","https://openalex.org/W2028305434","https://openalex.org/W2028474222","https://openalex.org/W2031107131","https://openalex.org/W2036700635","https://openalex.org/W2037718442","https://openalex.org/W2041230772","https://openalex.org/W2041438725","https://openalex.org/W2045171964","https://openalex.org/W2045903581","https://openalex.org/W2047884170","https://openalex.org/W2048566307","https://openalex.org/W2050123488","https://openalex.org/W2056388979","https://openalex.org/W2063812162","https://openalex.org/W2065874844","https://openalex.org/W2071418020","https://openalex.org/W2074483296","https://openalex.org/W2086545953","https://openalex.org/W2093681749","https://openalex.org/W2093828252","https://openalex.org/W2093897184","https://openalex.org/W2105575850","https://openalex.org/W2110705999","https://openalex.org/W2121651624","https://openalex.org/W2122224982","https://openalex.org/W2134823086","https://openalex.org/W2135710940","https://openalex.org/W2137422526","https://openalex.org/W2143515089","https://openalex.org/W2148239264","https://openalex.org/W2153150244","https://openalex.org/W2160603187","https://openalex.org/W2163815564","https://openalex.org/W2168221314","https://openalex.org/W2255883331","https://openalex.org/W2317480464","https://openalex.org/W4300098828"],"related_works":["https://openalex.org/W2109604162","https://openalex.org/W2041054923","https://openalex.org/W1811662369","https://openalex.org/W2056293062","https://openalex.org/W2001813194","https://openalex.org/W1511830919","https://openalex.org/W2026404267","https://openalex.org/W2403020376","https://openalex.org/W2093481224","https://openalex.org/W2028305434"],"abstract_inverted_index":{"The":[0,121],"therapeutic":[1],"effect":[2,48],"of":[3,6,15,32,49,54,63,86,112,164,175,183,192],"a":[4,13,39,173,185],"course":[5,174],"antidepressant":[7,50,94,122,156,176],"treatment":[8,51,67,96,142,180],"is":[9,28],"believed":[10],"to":[11,22,30,118,152],"involve":[12],"cascade":[14],"neuroadaptive":[16],"changes":[17],"in":[18,41,60,77,110,189],"gene":[19,187],"expression":[20,53,163,182],"leading":[21],"increased":[23,73,97,106],"neural":[24,33],"plasticity.":[25],"Because":[26],"glutamate":[27,57,193],"linked":[29],"mechanisms":[31],"plasticity,":[34],"this":[35],"transmitter":[36],"may":[37],"play":[38],"role":[40],"these":[42],"changes.":[43],"This":[44],"study":[45],"investigated":[46],"the":[47,55,64,87,113,144,154,162,190],"on":[52],"vesicular":[56],"transporters,":[58],"VGLUT1-3":[59],"brain":[61],"regions":[62,85,111],"rat.":[65],"Repeated":[66,101],"with":[68,143],"fluoxetine,":[69],"paroxetine":[70],"or":[71,166,178],"desipramine":[72],"VGLUT1":[74,98,107,129],"mRNA":[75,108,130],"abundance":[76,109,131],"frontal,":[78],"orbital,":[79],"cingulate":[80],"and":[81,84,115,124,135,148],"parietal":[82],"cortices,":[83],"hippocampus.":[88],"Immunoautoradiography":[89],"analysis":[90],"showed":[91],"that":[92,172],"repeated":[93,141],"drug":[95,177],"protein":[99],"expression.":[100],"electroconvulsive":[102],"shock":[103],"(ECS)":[104],"also":[105],"cortex":[114],"hippocampus":[116],"compared":[117],"sham":[119],"controls.":[120],"drugs":[123],"ECS":[125,179],"did":[126,158],"not":[127,159],"alter":[128],"after":[132,140],"acute":[133],"administration,":[134],"no":[136],"change":[137],"was":[138],"detected":[139],"antipsychotic":[145],"agents,":[146],"haloperidol":[147],"chlorpromazine.":[149],"In":[150],"contrast":[151],"VGLUT1,":[153,184],"different":[155],"treatments":[157],"commonly":[160],"increase":[161],"VGLUT2":[165],"VGLUT3":[167],"mRNA.":[168],"These":[169],"data":[170],"suggest":[171],"increases":[181],"key":[186],"involved":[188],"regulation":[191],"secretion.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1491963713","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
